NCT02030028View on ClinicalTrials.gov

ACTH Gel Therapy in Rheumatoid Arthritis

NACompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions

Rheumatoid Arthritis

Interventions

DRUG

ACTHAR gel

Subjects are given the ACTHAR gel subcutaneously twice per week for 12 weeks.

Trial Locations (1)

15261

University of Pittsburgh, Pittsburgh

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Mallinckrodt

INDUSTRY

lead

Dana Ascherman

OTHER